Sales of Johnson & Johnson’s diabetes drug Invokana have suffered since the FDA put a warning in the box on the label describing the product’s amputation risks. But in a nutshell, the bureau now says this warning has been removed. The FDA this week scrapped the warning in the box …
Read More »
FDA Commissioner Stephen Hahn, MD, was fresh from a controversy over the authorization for emergency use of restorative plasma to treat COVID-19 when he made waves again, this time promising on Twitter that the agency would review coronavirus vaccines for the elections of November. And Pfizer executives seem to be …
Read More »
Despite hundreds of potential therapies for COVID-19 seeking to make their case, very few have crossed the finish line. One graduate candidate, Regeneron’s two-antibody cocktail, has earned early plaudits – and now a pharmaceutical giant is jumping on board to boost production in a big way. Regeneron will partner with …
Read More »